Gaboury L - Search Results

1

The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression.

Goyette MA, Duhamel S, Aubert L, Pelletier A, Savage P, Thibault MP, Johnson RM, Carmeliet P, Basik M, Gaboury L, Muller WJ, Park M, Roux PP, Gratton JP, Côté JF. Goyette MA, et al. Among authors: gaboury l. Cell Rep. 2018 May 1;23(5):1476-1490. doi: 10.1016/j.celrep.2018.04.019. Cell Rep. 2018. PMID: 29719259 Free article.

2

Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumors.

Voisin L, Julien C, Duhamel S, Gopalbhai K, Claveau I, Saba-El-Leil MK, Rodrigue-Gervais IG, Gaboury L, Lamarre D, Basik M, Meloche S. Voisin L, et al. Among authors: gaboury l. BMC Cancer. 2008 Nov 17;8:337. doi: 10.1186/1471-2407-8-337. BMC Cancer. 2008. PMID: 19014680 Free PMC article.

3

The influence of tumor-host interactions in the stromal cell-derived factor-1/CXCR4 ligand/receptor axis in determining metastatic risk in breast cancer.

Hassan S, Ferrario C, Saragovi U, Quenneville L, Gaboury L, Baccarelli A, Salvucci O, Basik M. Hassan S, et al. Among authors: gaboury l. Am J Pathol. 2009 Jul;175(1):66-73. doi: 10.2353/ajpath.2009.080948. Epub 2009 Jun 4. Am J Pathol. 2009. PMID: 19497995 Free PMC article.

4

Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer.

Rose AA, Grosset AA, Dong Z, Russo C, Macdonald PA, Bertos NR, St-Pierre Y, Simantov R, Hallett M, Park M, Gaboury L, Siegel PM. Rose AA, et al. Among authors: gaboury l. Clin Cancer Res. 2010 Apr 1;16(7):2147-56. doi: 10.1158/1078-0432.CCR-09-1611. Epub 2010 Mar 9. Clin Cancer Res. 2010. PMID: 20215530

5

CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model.

Hassan S, Buchanan M, Jahan K, Aguilar-Mahecha A, Gaboury L, Muller WJ, Alsawafi Y, Mourskaia AA, Siegel PM, Salvucci O, Basik M. Hassan S, et al. Among authors: gaboury l. Int J Cancer. 2011 Jul 1;129(1):225-32. doi: 10.1002/ijc.25665. Epub 2010 Nov 12. Int J Cancer. 2011. PMID: 20830712

6

Sef downregulation by Ras causes MEK1/2 to become aberrantly nuclear localized leading to polyploidy and neoplastic transformation.

Duhamel S, Hébert J, Gaboury L, Bouchard A, Simon R, Sauter G, Basik M, Meloche S. Duhamel S, et al. Among authors: gaboury l. Cancer Res. 2012 Feb 1;72(3):626-35. doi: 10.1158/0008-5472.CAN-11-2126. Cancer Res. 2012. PMID: 22298595

7

Crk adaptor proteins act as key signaling integrators for breast tumorigenesis.

Fathers KE, Bell ES, Rajadurai CV, Cory S, Zhao H, Mourskaia A, Zuo D, Madore J, Monast A, Mes-Masson AM, Grosset AA, Gaboury L, Hallet M, Siegel P, Park M. Fathers KE, et al. Among authors: gaboury l. Breast Cancer Res. 2012 May 8;14(3):R74. doi: 10.1186/bcr3183. Breast Cancer Res. 2012. PMID: 22569336 Free PMC article.

8

MMP-9 expression varies according to molecular subtypes of breast cancer.

Yousef EM, Tahir MR, St-Pierre Y, Gaboury LA. Yousef EM, et al. BMC Cancer. 2014 Aug 23;14:609. doi: 10.1186/1471-2407-14-609. BMC Cancer. 2014. PMID: 25151367 Free PMC article.

9

Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study.

Boileau JF, Poirier B, Basik M, Holloway CM, Gaboury L, Sideris L, Meterissian S, Arnaout A, Brackstone M, McCready DR, Karp SE, Trop I, Lisbona A, Wright FC, Younan RJ, Provencher L, Patocskai E, Omeroglu A, Robidoux A. Boileau JF, et al. Among authors: gaboury l. J Clin Oncol. 2015 Jan 20;33(3):258-64. doi: 10.1200/JCO.2014.55.7827. Epub 2014 Dec 1. J Clin Oncol. 2015. PMID: 25452445 Clinical Trial.

10

ADP-ribosylation factor 1 expression regulates epithelial-mesenchymal transition and predicts poor clinical outcome in triple-negative breast cancer.

Schlienger S, Campbell S, Pasquin S, Gaboury L, Claing A. Schlienger S, et al. Among authors: gaboury l. Oncotarget. 2016 Mar 29;7(13):15811-27. doi: 10.18632/oncotarget.7515. Oncotarget. 2016. PMID: 26908458 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters